Literature DB >> 21870873

Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.

Swati Biswas1, Namita S Dodwadkar, Rupa R Sawant, Vladimir P Torchilin.   

Abstract

Surface grafting of liposomes with the wide variety of ligands including antibodies and other proteins is a promising approach for targeted delivery of therapeutics. In this paper, we describe a simple method of synthesizing a hydrazine-functionalized poly(ethylene glycol)-phosphatidylethanolamine (PEG-PE)-based amphiphilic polymer which can conjugate a variety of ligands via a reversible, pH-cleavable bond. In this method, the targeting ligand is attached to the distal end of the PEG chain, which facilitates its easy access to the targeted site of interaction. The reversible attachment of targeting ligands is useful especially in multifunctional liposomal systems, whereafter successfully performing the function of targeting to the specific site, the bulky ligands, such as proteins or antibodies, are cleaved off in response to an environmental stimulus to expose some other functionalities such as ligands for intracellular penetration or organelle-specific targeting. To investigate the applicability of the protocol, the model ligands monoclonal antinucleosome antibody 2C5 and antimyosin antibody 2G4, and glycoproteins concanavalin A (Con-A) and avidin were conjugated to the synthesized polymer and incorporated into liposomes. In vitro assays including biochemical, enzyme-linked immunosorbent, fluorescence microscopy, and flow cytometry were used to confirm three key characteristics of the modified and/or liposome-attached proteins: successful conjugation of the targeting ligands to the polymer, preservation of specific activity of the ligands after the conjugation and liposome attachment, and the facile pH-sensitive ligand detachment. Monoclonal antibody 2C5 and 2G4, immobilized on the liposome surface, retained their binding affinity to corresponding antigens as confirmed by ELISA. The Con A-bearing liposomes showed significantly higher agglutination in the presence of its substrate mannan compared to plain liposomes (PL) and avidin-functionalized liposomes bound specifically with biotin-agarose. The study on the pH-dependence showed that almost 80% of the hydrazone bond was cleaved after rather brief preincubation of the immunoliposomes at pH 5 for 0.5 to 1 h. Fluorescence microscopy and flow cytometry analysis of cancer cells (HeLa and MCF-7) treated with cancer cell-specific targeting ligand mAb 2C5-bearing liposomes showed enhanced cellular binding. Studies at low pH clearly confirmed the easy cleavability of the targeting ligand from the liposomes resulting in significantly less or virtually no cellular association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870873      PMCID: PMC3197796          DOI: 10.1021/bc2002133

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  33 in total

Review 1.  Multifunctional nanocarriers.

Authors:  Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2006-09-28       Impact factor: 15.470

Review 2.  Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates.

Authors:  S Zalipsky
Journal:  Bioconjug Chem       Date:  1995 Mar-Apr       Impact factor: 4.774

3.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

4.  Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.

Authors:  V Valero; A U Buzdar; R L Theriault; N Azarnia; G A Fonseca; J Willey; M Ewer; R S Walters; B Mackay; D Podoloff; D Booser; L W Lee; G N Hortobagyi
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium.

Authors:  V P Torchilin; A L Klibanov; L Huang; S O'Donnell; N D Nossiff; B A Khaw
Journal:  FASEB J       Date:  1992-06       Impact factor: 5.191

6.  Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.

Authors:  Xiao-Bing Xiong; Yue Huang; Wan-Liang Lu; Xuan Zhang; Hua Zhang; Tsuneji Nagai; Qiang Zhang
Journal:  J Pharm Sci       Date:  2005-08       Impact factor: 3.534

7.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.

Authors:  V P Torchilin; T S Levchenko; A N Lukyanov; B A Khaw; A L Klibanov; R Rammohan; G P Samokhin; K R Whiteman
Journal:  Biochim Biophys Acta       Date:  2001-04-02

8.  Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes.

Authors:  S Zalipsky
Journal:  Bioconjug Chem       Date:  1993 Jul-Aug       Impact factor: 4.774

9.  Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium.

Authors:  V P Torchilin; J Narula; E Halpern; B A Khaw
Journal:  Biochim Biophys Acta       Date:  1996-02-21

10.  Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.

Authors:  B A Khaw; T Yasuda; H K Gold; R C Leinbach; J A Johns; M Kanke; M Barlai-Kovach; H W Strauss; E Haber
Journal:  J Nucl Med       Date:  1987-11       Impact factor: 10.057

View more
  13 in total

1.  Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

Authors:  Swati Biswas; Pranali P Deshpande; Gemma Navarro; Namita S Dodwadkar; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-11-05       Impact factor: 12.479

Review 2.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 3.  Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.

Authors:  Muneeb Ahmed; Marwan Moussa; S Nahum Goldberg
Journal:  Chem Phys Lipids       Date:  2011-12-14       Impact factor: 3.329

4.  Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.

Authors:  Radhika Narayanaswamy; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2021-03-02       Impact factor: 4.200

5.  Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.

Authors:  Junhwa Shin; Pochi Shum; Jessica Grey; Shin-ichi Fujiwara; Guarov S Malhotra; Andres González-Bonet; Seok-Hee Hyun; Elaine Moase; Theresa M Allen; David H Thompson
Journal:  Mol Pharm       Date:  2012-10-03       Impact factor: 4.939

Review 6.  Immunoconjugates and long circulating systems: origins, current state of the art and future directions.

Authors:  Alexander Koshkaryev; Rupa Sawant; Madhura Deshpande; Vladimir Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2012-09-03       Impact factor: 15.470

7.  Intestinal absorption of fluorescently labeled nanoparticles.

Authors:  Spomenka Simovic; Yunmei Song; Thomas Nann; Tejal A Desai
Journal:  Nanomedicine       Date:  2015-03-16       Impact factor: 5.307

8.  Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer.

Authors:  Raj Kumar Thapa; Hanh Thuy Nguyen; Milan Gautam; Aarajana Shrestha; Eung Seok Lee; Sae Kwang Ku; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.

Authors:  Melissa Howard; Blaine J Zern; Aaron C Anselmo; Vladimir V Shuvaev; Samir Mitragotri; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2014-05-07       Impact factor: 15.881

10.  Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  J Drug Deliv       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.